Glow | GHK-CU, TB-500, BPC-157 Blend research-grade
Glow | GHK-CU, TB-500, BPC-157 Blend
$124.00 Add to cart
DSIP (Delta Sleep-Inducing Peptide) research-grade DSIP (Delta Sleep-Inducing Peptide) Price range: $36.00 through $50.00
SNAP-8 Peptide research-grade SNAP-8 Peptide Price range: $32.00 through $90.00

Glow | GHK-CU, TB-500, BPC-157 Blend

$124.00

Laboratory-grade Glow | GHK-CU, TB-500, BPC-157 Blend is a multi-peptide catalog combination of GHK-Cu, TB-500, and BPC-157 research materials. Research buyers select this listing for pre-clinical work on multi-peptide assay panels—not for clinical, veterinary, or consumer use.

For Research Use Only. Not for human use.

In stock

COA GLOW

For Research Use Only — Not for Human Consumption
Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

Accepted Payment Methods

For Research Use Only. Not for human use.

Glow | GHK-CU, TB-500, BPC-157 Blend research-grade

Overview

Laboratory-grade Glow | GHK-CU, TB-500, BPC-157 Blend presents as a multi-peptide catalog combination of GHK-Cu, TB-500, and BPC-157 research materials. Nationwide lists this SKU for controlled research programs focused on multi-peptide assay panels—not for clinical, veterinary, or consumer use.

Research buyers specify Glow | GHK-CU, TB-500, BPC-157 Blend when protocols require a characterized input for multi-peptide assay panels. Typical deployments include cell-based or cell-free assays, method development plates, and pathway-mapping models executed under institutional laboratory SOPs.

The catalog record supports pre-clinical documentation trails across replicates and partner sites. Archive shipment paperwork with study files whenever Glow | GHK-CU, TB-500, BPC-157 Blend enters a new experimental series.

Research Context for Glow | GHK-CU, TB-500, BPC-157 Blend

Work involving Glow | GHK-CU, TB-500, BPC-157 Blend typically focuses on in vitro systems, assay development, and mechanistic model studies.

Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites.

Published literature can inform starting ranges for related experimental designs. Each laboratory should still validate performance with its own instruments, plates, and detection chemistry.

Pilot runs are useful before committing larger plate sets, especially when detection chemistry or incubation windows are being optimized.

Documented Attributes

Key catalog attributes for this material include:

  • Research-grade material intended for laboratory investigation only
  • Catalog labeling aligned with research procurement channels
  • Suitable for method development and comparative assay workflows
  • Documentation packages available where provided for the listed lot

Laboratory Handling Notes

Receiving and Identity Checks

Before opening a vial of Glow | GHK-CU, TB-500, BPC-157 Blend, confirm the physical label against the purchase order and packing list.

Retain outer packaging until identity checks are complete, and report damaged seals to purchasing before experimental work continues.

Reconstitution and Aliquoting

Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage.

Record lot identifiers in laboratory notebooks before reconstitution. Verify solvent compatibility and storage temperature against your validated process.

Prepare assay buffers and consumables before opening the vial to reduce hold time. Keep unused aliquots labeled with date, solvent, and concentration for later repeats.

Chain of Custody

Keep chain-of-custody notes with inventory checks when material moves between freezers or benches.

Use dedicated spatulas and clean balances to avoid cross-contamination between catalog items. Schedule thaw cycles intentionally rather than repeated freeze-thaw of the same aliquot.

Secondary containment trays reduce spill risk during multi-step reconstitution. Cold-chain interruptions should be noted even when the vial remains sealed.

Why Laboratories Source Glow | GHK-CU, TB-500, BPC-157 Blend

Procurement and research teams often select this catalog item because it supports:

  • Clear research-use labeling for compliance-aligned purchasing
  • Consistent product identification across multi-lot studies
  • Fit for reference, screening, and mechanistic laboratory models
  • Straightforward catalog support for planning and documentation

Study Planning and Quality Documentation

Before starting experimental work with Glow | GHK-CU, TB-500, BPC-157 Blend, review any COA or quality files provided with the shipment.

Align your protocol with institutional research requirements and keep use within the labeled research context.

File catalog documentation with the study records at receipt. These steps help keep experiments comparable over time when using Glow | GHK-CU, TB-500, BPC-157 Blend in sequential study phases.

Method Development Tips

Method development often begins with small pilot plates before larger screening panels.

Document buffer lots, incubation times, and detection settings alongside the material lot number.

If results diverge from historical baselines, re-check reconstitution volume and storage history first. Shared equipment logs help explain variance when multiple operators run the same protocol.

Inventory and Training

Update digital inventory immediately after opening a new lot of Glow | GHK-CU, TB-500, BPC-157 Blend.

Training new staff on labeling conventions reduces mix-ups across similar catalog SKUs. When transferring methods between sites, share both the written SOP and the lot metadata package.

Dispose of residual solutions according to institutional chemical hygiene rules. Do not repurpose research materials for any non-laboratory application.

Periodic inventory reconciliation keeps expired or depleted lots from entering active workflows. For related catalog options, browse adjacent research categories on this site after confirming your assay needs.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

PubMed (NIH/NLM) records related to this compound for laboratory literature review. Inclusion does not imply suitability for any use beyond controlled research. Each note below is a research-framed summary using compliance-safe wording.

Showing 192 PubMed records. Displaying 10 per page.

  1. Ho EN et al. (2012). Doping control analysis of TB-500, a synthetic version of an active region of thymosin… [PMID: 23084823]

    Laboratory literature summary: Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  2. Judák P et al. (2017). Adsorption effects of the doping relevant peptides Insulin Lispro, Synachten, TB-500… [PMID: 28887173]

    Laboratory literature summary: Adsorption effects of the doping relevant peptides Insulin Lispro, Synachten, TB-500 and GHRP 5. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  3. Esposito S et al. (2012). Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin… [PMID: 22962027]

    Laboratory literature summary: Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  4. Józwiak M et al. (2025). Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature… [PMID: 40005999]

    Laboratory literature summary: Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  5. Vasireddi N et al. (2025). Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review [PMID: 40756949]

    Laboratory literature summary: Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  6. Gwyer D et al. (2019). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 30915550]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  7. Lee E et al. (2021). Intra-Articular parenteral-route administration of BPC 157 for Multiple Types of Knee Pain [PMID: 34324435]

    Laboratory literature summary: Intra-Articular parenteral-route administration of BPC 157 for Multiple Types of Knee Pain. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  8. Seiwerth S et al. (2021). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 34267654]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  9. Seiwerth S et al. (2018). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 29998800]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  10. McGuire FP et al. (2025). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 40789979]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  11. Chang CH et al. (2011). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 21030672]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  12. Lee E et al. (2024). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 39325560]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  13. Seiwerth S et al. (2014). BPC 157 and blood vessels [PMID: 23782145]

    Laboratory literature summary: BPC 157 and blood vessels. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  14. Sikiric P et al. (2024). The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its… [PMID: 38675421]

    Laboratory literature summary: The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  15. Sikiric P et al. (2023). Stable Gastric Pentadecapeptide BPC 157: Prompt Particular Activation of Collateral… [PMID: 36200148]

    Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157: Prompt Particular Activation of Collateral Pathways. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  16. Vukojevic J et al. (2022). Pentadecapeptide BPC 157 and the central nervous system [PMID: 34380875]

    Laboratory literature summary: Pentadecapeptide BPC 157 and the central nervous system. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  17. Park JM et al. (2020). BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and… [PMID: 32445447]

    Laboratory literature summary: BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  18. Sikiric P et al. (2022). Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion… [PMID: 35125818]

    Laboratory literature summary: Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  19. Sikiric P et al. (2014). Stable gastric pentadecapeptide BPC 157-NO-system relation [PMID: 23755725]

    Laboratory literature summary: Stable gastric pentadecapeptide BPC 157-NO-system relation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  20. Sikiric P et al. (2020). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 32329684]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  21. Seiwerth S et al. (1997). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 9403790]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  22. Deek SA (2021). BPC 157 as Potential investigation for COVID-19 [PMID: 34798584]

    Laboratory literature summary: BPC 157 as Potential investigation for COVID-19. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  23. Staresinic M et al. (2022). Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle [PMID: 36551977]

    Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  24. Sikiric P et al. (2023). Stable Gastric Pentadecapeptide BPC 157-Possible Novel research protocol of Glaucoma… [PMID: 37513963]

    Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157-Possible Novel research protocol of Glaucoma and Other Ocular Conditions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  25. Whitehouse M (2025). Concerning BPC-157, a natural pentadecapeptide, that acts as a cytoprotectant and is… [PMID: 40759852]

    Laboratory literature summary: Concerning BPC-157, a natural pentadecapeptide, that acts as a cytoprotectant and is believed to protect the gastro-intestinal tract (GIT). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  26. Bajramagic S et al. (2024). Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses research protocol… [PMID: 39204186]

    Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses research protocol in Rats-A Review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  27. Sikiric P et al. (2023). Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis… [PMID: 37242459]

    Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis Function. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  28. Sikiric P et al. (2016). Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications [PMID: 27138887]

    Laboratory literature summary: Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  29. Sikiric P et al. (2025). Stable Gastric Pentadecapeptide BPC 157 as a research protocol and laboratory profile… [PMID: 40573323]

    Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157 as a research protocol and laboratory profile Key: A Special Beneficial Pleiotropic Effect…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  30. Yuan C et al. (2026). From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management [PMID: 41898733]

    Laboratory literature summary: From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  31. Jung YH et al. (2022). The anti-nociceptive effect of BPC-157 on the incisional pain model in rats [PMID: 35449779]

    Laboratory literature summary: The anti-nociceptive effect of BPC-157 on the incisional pain model in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  32. Mateescu DM et al. (2026). BPC-157 as an Investigational Peptide investigational: Biopharmaceutical Challenges,… [PMID: 42198317]

    Laboratory literature summary: BPC-157 as an Investigational Peptide investigational: Biopharmaceutical Challenges, Formulation Strategies, and Translational…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  33. Sikiric P et al. (2025). BPC 157 research protocol: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and… [PMID: 41155565]

    Laboratory literature summary: BPC 157 research protocol: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  34. Zemba Cilic A et al. (2022). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 35884767]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  35. Sikiric P et al. (2011). Stable gastric pentadecapeptide BPC 157: novel research protocol in gastrointestinal tract [PMID: 21548867]

    Laboratory literature summary: Stable gastric pentadecapeptide BPC 157: novel research protocol in gastrointestinal tract. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  36. Zemba Cilic A et al. (2021). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 32956773]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  37. Sikiric P et al. (2020). Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive… [PMID: 31158953]

    Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  38. Sikiric P et al. (2022). Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide research… [PMID: 36359218]

    Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide research protocol in the Heart Disturbances, Myocardial…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  39. Zivanovic-Posilovic G et al. (2016). Stable gastric pentadecapeptide BPC 157 and bupivacaine [PMID: 27815173]

    Laboratory literature summary: Stable gastric pentadecapeptide BPC 157 and bupivacaine. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  40. Stambolija V et al. (2016). BPC 157: The counteraction of succinylcholine, hyperkalemia, and arrhythmias [PMID: 27060013]

    Laboratory literature summary: BPC 157: The counteraction of succinylcholine, hyperkalemia, and arrhythmias. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  41. Demirtaş H et al. (2025). Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats… [PMID: 40005408]

    Laboratory literature summary: Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower-Extremity…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  42. Sikiric P et al. (2018). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 29879879]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  43. Grubisic MM et al. (2025). Withdrawn: Stable Gastric Pentadecapeptide BPC 157 as a research protocol of Severe… [PMID: 39865815]

    Laboratory literature summary: Withdrawn: Stable Gastric Pentadecapeptide BPC 157 as a research protocol of Severe Electrolyte Disturbances in Rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  44. Yıldırım AK et al. (2026). Protective effects of BPC 157 in rats with experimentally induced lower extremity… [PMID: 42204242]

    Laboratory literature summary: Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  45. Kralj T et al. (2021). Stable Gastric Pentadecapeptide BPC 157 research protocol of Rat Glaucoma [PMID: 35052769]

    Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157 research protocol of Rat Glaucoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  46. Sikiric P et al. (2013). Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157 [PMID: 22950504]

    Laboratory literature summary: Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  47. Barisic I et al. (2022). Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced… [PMID: 35203478]

    Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  48. Matek D et al. (2025). Stable Gastric Pentadecapeptide BPC 157 as research protocol After Surgical Detachment… [PMID: 39861766]

    Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157 as research protocol After Surgical Detachment of the Quadriceps Muscle from Its Attachments for…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  49. Jelińska J et al. (2026). BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase [PMID: 42278509]

    Laboratory literature summary: BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  50. Smoday IM et al. (2023). Pentadecapeptide BPC 157 as research protocol for Inferior Caval Vein Embolization:… [PMID: 37895979]

    Laboratory literature summary: Pentadecapeptide BPC 157 as research protocol for Inferior Caval Vein Embolization: Recovery of Sodium Laurate-Post-Embolization…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  51. Józwiak M et al. (2025). Reply to Sikiric et al. BPC 157 research protocol: Targeting Angiogenesis and Nitric… [PMID: 41155566]

    Laboratory literature summary: Reply to Sikiric et al. BPC 157 research protocol: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  52. Kolovrat M et al. (2020). Pentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion [PMID: 32547687]

    Laboratory literature summary: Pentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  53. Vukusic D et al. (2024). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 38583442]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  54. Tepes M et al. (2021). Corrigendum: Stable Gastric Pentadecapeptide BPC 157 research protocol for Primary… [PMID: 35126157]

    Laboratory literature summary: Corrigendum: Stable Gastric Pentadecapeptide BPC 157 research protocol for Primary Abdominal Compartment Syndrome in Rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  55. Grgic T et al. (2016). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 26875638]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  56. Huang BS et al. (2022). Pentadecapeptide BPC 157 efficiently reduces radiation-induced liver injury and lipid… [PMID: 36228773]

    Laboratory literature summary: Pentadecapeptide BPC 157 efficiently reduces radiation-induced liver injury and lipid accumulation through Kruppel-like factor 4…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  57. Sikiric P et al. (2025). Acute Compartment Syndrome and Intra-Abdominal Hypertension, Decompression, Current… [PMID: 40573261]

    Laboratory literature summary: Acute Compartment Syndrome and Intra-Abdominal Hypertension, Decompression, Current Pharmacotherapy, and Stable Gastric Pentadecapeptide…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  58. Gojkovic S et al. (2021). BPC 157 research protocol and the Permanent Occlusion of the Superior Sagittal Sinus… [PMID: 34203464]

    Laboratory literature summary: BPC 157 research protocol and the Permanent Occlusion of the Superior Sagittal Sinus in Rat: Vascular Recruitment. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  59. Vukojević J et al. (2020). The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in… [PMID: 32558293]

    Laboratory literature summary: The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  60. Sikiric P et al. (2002). Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances [PMID: 11978191]

    Laboratory literature summary: Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  61. Sikiric P et al. (2017). Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally,… [PMID: 28228068]

    Laboratory literature summary: Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  62. Masnec S et al. (2025). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 41471311]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  63. Japjec M et al. (2021). Stable Gastric Pentadecapeptide BPC 157 as a research protocol for the Disable… [PMID: 34829776]

    Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157 as a research protocol for the Disable Myotendinous Junctions in Rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  64. Zlatar M et al. (2021). BPC 157 as a research protocol for Retinal Ischemia Induced by Retrobulbar Application… [PMID: 34177567]

    Laboratory literature summary: BPC 157 as a research protocol for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  65. Kalogjera L et al. (2023). Stomach perforation-induced general occlusion/occlusion-like syndrome and stable… [PMID: 37545637]

    Laboratory literature summary: Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 research protocol effect. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  66. Zemba M et al. (2015). BPC 157 antagonized the general anaesthetic potency of thiopental and reduced… [PMID: 26563892]

    Laboratory literature summary: BPC 157 antagonized the general anaesthetic potency of thiopental and reduced prolongation of anaesthesia induced by L-NAME/thiopental…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  67. Hsieh MJ et al. (2020). Modulatory effects of BPC 157 on vasomotor tone and the activation of… [PMID: 33051481]

    Laboratory literature summary: Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  68. Sever AZ et al. (2019). Stable gastric pentadecapeptide BPC 157 in the research protocol of the rats with bile… [PMID: 30690000]

    Laboratory literature summary: Stable gastric pentadecapeptide BPC 157 in the research protocol of the rats with bile duct ligation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  69. Tepes M et al. (2021). Stable Gastric Pentadecapeptide BPC 157 research protocol for Primary Abdominal… [PMID: 34966273]

    Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157 research protocol for Primary Abdominal Compartment Syndrome in Rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  70. Tepes M et al. (2023). Stable Gastric Pentadecapeptide BPC 157 research protocol: Effect on Reperfusion… [PMID: 38004420]

    Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157 research protocol: Effect on Reperfusion Following Maintained Intra-Abdominal Hypertension…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  71. Strinic D et al. (2017). BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine,… [PMID: 28797793]

    Laboratory literature summary: BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  72. Baric M et al. (2016). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 26872976]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  73. Mirković I et al. (2020). Pentadecapeptide BPC 157 shortens duration of tetracaine- and oxybuprocaine-induced… [PMID: 34177048]

    Laboratory literature summary: Pentadecapeptide BPC 157 shortens duration of tetracaine- and oxybuprocaine-induced corneal anesthesia in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  74. Gojkovic S et al. (2020). Pentadecapeptide BPC 157 resolves suprahepatic occlusion of the inferior caval vein,… [PMID: 32226643]

    Laboratory literature summary: Pentadecapeptide BPC 157 resolves suprahepatic occlusion of the inferior caval vein, Budd-Chiari syndrome model in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  75. Chang CH et al. (2014). Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon… [PMID: 25415472]

    Laboratory literature summary: Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  76. Rasic D et al. (2021). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 34572392]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  77. Sikiric P et al. (2012). Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157 [PMID: 22300085]

    Laboratory literature summary: Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  78. Cesarec V et al. (2013). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 23220707]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  79. Sikiric P et al. (2006). Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease… [PMID: 17186181]

    Laboratory literature summary: Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  80. Premuzic Mestrovic I et al. (2023). Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric… [PMID: 37513889]

    Laboratory literature summary: Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 research protocol. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  81. Matek D et al. (2026). Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone… [PMID: 41754849]

    Laboratory literature summary: Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction research protocol Perspectives with…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  82. Masnec S et al. (2015). Perforating corneal injury in rat and pentadecapeptide BPC 157 [PMID: 25912999]

    Laboratory literature summary: Perforating corneal injury in rat and pentadecapeptide BPC 157. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  83. Perovic D et al. (2019). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 31266512]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  84. Keremi B et al. (2009). Antiinflammatory effect of BPC 157 on experimental periodontitis in rats [PMID: 20388954]

    Laboratory literature summary: Antiinflammatory effect of BPC 157 on experimental periodontitis in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  85. Sikiric P et al. (1994). The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and… [PMID: 7904712]

    Laboratory literature summary: The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  86. Duzel A et al. (2017). Stable gastric pentadecapeptide BPC 157 in the investigation of colitis and ischemia… [PMID: 29358856]

    Laboratory literature summary: Stable gastric pentadecapeptide BPC 157 in the investigation of colitis and ischemia and reperfusion in rats: New insights. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  87. Udovicic M et al. (2021). Stable Gastric Pentadecapeptide BPC 157 research protocol for Monocrotaline-Induced… [PMID: 34356886]

    Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157 research protocol for Monocrotaline-Induced Pulmonary Hypertension in Rats Leads to Prevention…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  88. Sikirić P et al. (1997). Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in… [PMID: 9073154]

    Laboratory literature summary: Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  89. Stupnisek M et al. (2015). Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in… [PMID: 25897838]

    Laboratory literature summary: Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats studied with Heparin, Warfarin, L-NAME and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  90. Tlak Gajger I et al. (2018). Stable gastric pentadecapeptide BPC 157 in honeybee (Apis mellifera) research… [PMID: 29682749]

    Laboratory literature summary: Stable gastric pentadecapeptide BPC 157 in honeybee (Apis mellifera) research protocol, to control Nosema ceranae invasions in apiary…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  91. Xue XC et al. (2004). Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats [PMID: 15052688]

    Laboratory literature summary: Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  92. Gamulin O et al. (2022). Fourier Transform Infrared Spectroscopy Reveals Molecular Changes in Blood Vessels of… [PMID: 36551886]

    Laboratory literature summary: Fourier Transform Infrared Spectroscopy Reveals Molecular Changes in Blood Vessels of Rats studied with Pentadecapeptide BPC 157. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  93. Boban Blagaic A et al. (2009). Gastric pentadecapeptide BPC 157 counteracts morphine-induced analgesia in mice [PMID: 20388962]

    Laboratory literature summary: Gastric pentadecapeptide BPC 157 counteracts morphine-induced analgesia in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  94. Strbe S et al. (2023). Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone… [PMID: 37375736]

    Laboratory literature summary: Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  95. Škrlec K et al. (2018). Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide… [PMID: 30191288]

    Laboratory literature summary: Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  96. Boban Blagaic A et al. (2005). Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats [PMID: 15840402]

    Laboratory literature summary: Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  97. Sikiric P et al. (2001). Anxiolytic effect of BPC-157, a gastric pentadecapeptide: shock probe/burying test and… [PMID: 11742568]

    Laboratory literature summary: Anxiolytic effect of BPC-157, a gastric pentadecapeptide: shock probe/burying test and light/dark test. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  98. Strbe S et al. (2021). Over-exposure level Lithium Toxicity as an Occlusive-like Syndrome in Rats and Gastric… [PMID: 34829735]

    Laboratory literature summary: Over-exposure level Lithium Toxicity as an Occlusive-like Syndrome in Rats and Gastric Pentadecapeptide BPC 157. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  99. Perovic D et al. (2022). Novel investigational Effects in Rat Spinal Cord Injuries: Recovery of the Definitive… [PMID: 35678659]

    Laboratory literature summary: Novel investigational Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  100. Duplancic B et al. (2014). Pentadecapeptide BPC 157 and anaphylactoid reaction in rats and mice after intravenous… [PMID: 24486708]

    Laboratory literature summary: Pentadecapeptide BPC 157 and anaphylactoid reaction in rats and mice after intravenous dextran and white egg administration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  101. Lozic M et al. (2020). In relation to NO-System, Stable Pentadecapeptide BPC 157 Counteracts… [PMID: 32566305]

    Laboratory literature summary: In relation to NO-System, Stable Pentadecapeptide BPC 157 Counteracts Lidocaine-Induced Adverse Effects in Rats and Depolarisation In Vitro. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  102. Djakovic Z et al. (2016). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 27895400]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  103. Stupnisek M et al. (2012). Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation… [PMID: 21840572]

    Laboratory literature summary: Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats studied with heparin, warfarin or aspirin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  104. Mikus D et al. (2001). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 11718984]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  105. Smoday IM et al. (2022). Research protocol Effect of the Stable Gastric Pentadecapeptide BPC 157 on Acute… [PMID: 35740321]

    Laboratory literature summary: research protocol Effect of the Stable Gastric Pentadecapeptide BPC 157 on Acute Pancreatitis as Vascular Failure-Induced Severe…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  106. Brcic L et al. (2009). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 20388964]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  107. Cesar LB et al. (2020). Bowel adhesion and research protocol with the stable gastric pentadecapeptide BPC 157,… [PMID: 33251034]

    Laboratory literature summary: Bowel adhesion and research protocol with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  108. Tian T et al. (2023). Stable Isotope Labeling-Based Nontargeted Strategy for Characterization of the In… [PMID: 37959764]

    Laboratory literature summary: Stable Isotope Labeling-Based Nontargeted Strategy for Characterization of the In Vitro Metabolic Profile of a Novel Doping BPC-157 in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  109. Cox HD et al. (2017). Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H [PMID: 28035768]

    Laboratory literature summary: Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  110. Grubisic MM et al. (2026). Stable Gastric Pentadecapeptide BPC 157 as a research protocol of Severe Electrolyte… [PMID: 41832718]

    Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157 as a research protocol of Severe Electrolyte Disturbances in Rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  111. Wu H et al. (2020). Clopidogrel-Induced Gastric Injury in Rats is Attenuated by Stable Gastric… [PMID: 33376304]

    Laboratory literature summary: Clopidogrel-Induced Gastric Injury in Rats is Attenuated by Stable Gastric Pentadecapeptide BPC 157. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  112. Sikiric P et al. (2010). Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric… [PMID: 20166993]

    Laboratory literature summary: Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  113. Grabarevic Z et al. (1997). The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in… [PMID: 9403788]

    Laboratory literature summary: The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  114. Cerovecki T et al. (2010). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 20225319]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  115. Knezevic M et al. (2021). Occluded Superior Mesenteric Artery and Vein. research protocol with the Stable… [PMID: 34356860]

    Laboratory literature summary: Occluded Superior Mesenteric Artery and Vein. research protocol with the Stable Gastric Pentadecapeptide BPC 157. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  116. Novinscak T et al. (2008). Gastric pentadecapeptide BPC 157 as an effective research protocol for muscle crush… [PMID: 18668315]

    Laboratory literature summary: Gastric pentadecapeptide BPC 157 as an effective research protocol for muscle crush injury in the rat. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  117. Medvidovic-Grubisic M et al. (2017). Hypermagnesemia disturbances in rats, NO-related: pentadecapeptide BPC 157 abrogates,… [PMID: 28210905]

    Laboratory literature summary: Hypermagnesemia disturbances in rats, NO-related: pentadecapeptide BPC 157 abrogates, L-NAME and L-arginine worsen. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  118. Sever M et al. (2009). Gastric pentadecapeptide BPC 157 and short bowel syndrome in rats [PMID: 19093208]

    Laboratory literature summary: Gastric pentadecapeptide BPC 157 and short bowel syndrome in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  119. Pevec D et al. (2010). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 20190676]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  120. Drmic D et al. (2018). Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC… [PMID: 30622376]

    Laboratory literature summary: Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC 157, L-NAME and L-arginine. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  121. Balenovic D et al. (2009). Inhibition of methyldigoxin-induced arrhythmias by pentadecapeptide BPC 157: a… [PMID: 19465062]

    Laboratory literature summary: Inhibition of methyldigoxin-induced arrhythmias by pentadecapeptide BPC 157: a relation with NO-system. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  122. Petrovic I et al. (2011). BPC 157 research protocol to detriment sphincters failure-esophagitis-pancreatitis in… [PMID: 22204800]

    Laboratory literature summary: BPC 157 research protocol to detriment sphincters failure-esophagitis-pancreatitis in rat and acute pancreatitis research subjects low…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  123. Jandric I et al. (2013). Salutary effect of gastric pentadecapeptide BPC 157 in two different stress urinary… [PMID: 23478678]

    Laboratory literature summary: Salutary effect of gastric pentadecapeptide BPC 157 in two different stress urinary incontinence models in research models rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  124. Sikiric P et al. (2026). Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC… [PMID: 41901308]

    Laboratory literature summary: Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  125. Sikiric P et al. (1997). Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory… [PMID: 9403784]

    Laboratory literature summary: Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  126. Lazić R et al. (2005). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 16117343]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  127. Bilic M et al. (2005). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 15774286]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  128. Staresinic M et al. (2003). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 14554208]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  129. Jelovac N et al. (1999). Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect… [PMID: 10499368]

    Laboratory literature summary: Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  130. Tlak Gajger I et al. (2021). Physiological and Immunological Status of Adult Honeybees (Apis mellifera) Fed Sugar… [PMID: 34571768]

    Laboratory literature summary: Physiological and Immunological Status of Adult Honeybees (Apis mellifera) Fed Sugar Syrup Supplemented with Pentadecapeptide BPC 157. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  131. Klicek R et al. (2013). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 24304574]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  132. Madzarac G et al. (2026). Tracheocutaneous Fistula Resolved by Pentadecapeptide BPC 157 research protocol… [PMID: 41599743]

    Laboratory literature summary: Tracheocutaneous Fistula Resolved by Pentadecapeptide BPC 157 research protocol Through the NO-System-Triple NO-Agent Approach in Rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  133. Kalogjera L et al. (1997). Exposure level-dependent protective effect of BPC 157 on capsaicin-induced rhinitis in… [PMID: 9065615]

    Laboratory literature summary: exposure level-dependent protective effect of BPC 157 on capsaicin-induced rhinitis in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  134. Sikiric P et al. (2003). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 12781609]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  135. Yildirim AK et al. (2026). Endothelium-Dependent Nitric Oxide-Mediated Vasorelaxant Effects of BPC 157 in… [PMID: 42123221]

    Laboratory literature summary: Endothelium-Dependent Nitric Oxide-Mediated Vasorelaxant Effects of BPC 157 in research subjects Internal Mammary Artery. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  136. Klicek R et al. (2008). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 18818478]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  137. Sikirić P et al. (1997). The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine… [PMID: 9298922]

    Laboratory literature summary: The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  138. Drmic D et al. (2017). Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by… [PMID: 28839430]

    Laboratory literature summary: Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  139. Konosic S et al. (2019). Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats:… [PMID: 31976029]

    Laboratory literature summary: Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  140. Knezevic M et al. (2021). Complex Syndrome of the Complete Occlusion of the End of the Superior Mesenteric Vein,… [PMID: 34440233]

    Laboratory literature summary: Complex Syndrome of the Complete Occlusion of the End of the Superior Mesenteric Vein, Opposed with the Stable Gastric Pentadecapeptide…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  141. Sikiric P et al. (1999). The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new… [PMID: 10672992]

    Laboratory literature summary: The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  142. Sikirić P et al. (1997). Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect… [PMID: 9149058]

    Laboratory literature summary: Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  143. Sikirić P et al. (1996). Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by… [PMID: 8769287]

    Laboratory literature summary: Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin, and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  144. Gjurasin M et al. (2010). Peptide research protocol with pentadecapeptide BPC 157 in traumatic nerve injury [PMID: 19903499]

    Laboratory literature summary: Peptide research protocol with pentadecapeptide BPC 157 in traumatic nerve injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  145. Kokot A et al. (2016). NO system dependence of atropine-induced mydriasis and L-NAME- and L-arginine-induced… [PMID: 26698393]

    Laboratory literature summary: NO system dependence of atropine-induced mydriasis and L-NAME- and L-arginine-induced miosis: Reversal by the pentadecapeptide BPC 157…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  146. Vuksic T et al. (2007). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 17713731]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  147. Sucic M et al. (2019). Research protocol of the rat hemorrhagic cystitis induced by cyclophosphamide. Stable… [PMID: 31401154]

    Laboratory literature summary: research protocol of the rat hemorrhagic cystitis induced by cyclophosphamide. Stable gastric pentadecapeptide BPC 157, L-arginine, L-NAME. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  148. Sikirić P et al. (1996). Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and… [PMID: 8689934]

    Laboratory literature summary: Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  149. Boban-Blagaic A et al. (2006). The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol… [PMID: 16369461]

    Laboratory literature summary: The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. The effect of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  150. Smoday IM et al. (2026). Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as research protocol… [PMID: 42356491]

    Laboratory literature summary: Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as research protocol in Rats-A Cytoprotection Approach. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  151. Sikiric P et al. (1999). Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or… [PMID: 10672991]

    Laboratory literature summary: Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  152. Barisic I et al. (2013). Mortal hyperkalemia disturbances in rats are NO-system related. The life saving effect… [PMID: 23327997]

    Laboratory literature summary: Mortal hyperkalemia disturbances in rats are NO-system related. The life saving effect of pentadecapeptide BPC 157. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  153. Amic F et al. (2018). Bypassing major venous occlusion and duodenal lesions in rats, and research protocol… [PMID: 30598581]

    Laboratory literature summary: Bypassing major venous occlusion and duodenal lesions in rats, and research protocol with the stable gastric pentadecapeptide BPC 157,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  154. Knezevic M et al. (2021). Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways… [PMID: 34073625]

    Laboratory literature summary: Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  155. Gojkovic S et al. (2021). Robert's Intragastric Alcohol-Induced Gastric Lesion Model as an Escalated General… [PMID: 34680419]

    Laboratory literature summary: Robert's Intragastric Alcohol-Induced Gastric Lesion Model as an Escalated General Peripheral and Central Syndrome, Counteracted by the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  156. Sikiric P et al. (2026). Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2… [PMID: 41754776]

    Laboratory literature summary: Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  157. Krivic A et al. (2006). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 16583442]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  158. Ilic S et al. (2011). Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced… [PMID: 21295044]

    Laboratory literature summary: Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  159. Sikiric P et al. (1999). A behavioural study of the effect of pentadecapeptide BPC 157 in neurodegeneration… [PMID: 10672997]

    Laboratory literature summary: A behavioural study of the effect of pentadecapeptide BPC 157 in neurodegeneration research models's disease models in mice and gastric…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  160. Petek M et al. (1999). Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and mice [PMID: 10672996]

    Laboratory literature summary: Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  161. Blagaic AB et al. (2004). The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol… [PMID: 15381050]

    Laboratory literature summary: The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  162. Belosic Halle Z et al. (2017). Class observed outcomes in study models: decreased pressure in the lower oesophageal and the pyloric… [PMID: 28516373]

    Laboratory literature summary: Class observed outcomes in study models: decreased pressure in the lower oesophageal and the pyloric sphincters after the administration of dopamine…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  163. Skorjanec S et al. (2015). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 26348082]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  164. Jelovac N et al. (1998). A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by… [PMID: 9547930]

    Laboratory literature summary: A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  165. Sikiric P et al. (1993). Hepatoprotective effect of BPC 157, a 15-amino acid peptide, on liver lesions induced… [PMID: 7901724]

    Laboratory literature summary: Hepatoprotective effect of BPC 157, a 15-amino acid peptide, on liver lesions induced by either restraint stress or bile duct and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  166. Sebecić B et al. (1999). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 10071911]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  167. Vukojević J et al. (2018). Rat inferior caval vein (ICV) ligature and particular new insights with the stable… [PMID: 29510201]

    Laboratory literature summary: Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  168. Jelovac N et al. (1999). The effect of a novel pentadecapeptide BPC 157 on development of tolerance and… [PMID: 10707891]

    Laboratory literature summary: The effect of a novel pentadecapeptide BPC 157 on development of tolerance and physical dependence following repeated administration of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  169. Tudor M et al. (2010). Traumatic brain injury in mice and pentadecapeptide BPC 157 effect [PMID: 19931318]

    Laboratory literature summary: Traumatic brain injury in mice and pentadecapeptide BPC 157 effect. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  170. Lojo N et al. (2016). Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on… [PMID: 27627764]

    Laboratory literature summary: Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on Gastrointestinal, Liver, and Brain Lesions, Failed…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  171. Luetic K et al. (2017). Cyclophosphamide induced stomach and duodenal lesions as a NO-system disturbance in… [PMID: 28255738]

    Laboratory literature summary: Cyclophosphamide induced stomach and duodenal lesions as a NO-system disturbance in rats: L-NAME, L-arginine, stable gastric…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  172. Ilic S et al. (2010). High hepatotoxic exposure level of paracetamol produces generalized convulsions and… [PMID: 20436226]

    Laboratory literature summary: High hepatotoxic exposure level of paracetamol produces generalized convulsions and brain damage in rats. A counteraction with the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  173. Bilic Z et al. (2021). Novel insight into Robert's cytoprotection: complex investigational effect of… [PMID: 35485358]

    Laboratory literature summary: Novel insight into Robert's cytoprotection: complex investigational effect of cytoprotective pentadecapeptide pentadecapeptide BPC 157…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  174. Vitaic S et al. (2017). Nonsteroidal anti-inflammatory drugs-induced failure of lower esophageal and pyloric… [PMID: 28614776]

    Laboratory literature summary: Nonsteroidal anti-inflammatory drugs-induced failure of lower esophageal and pyloric sphincter and counteraction of sphincters failure…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  175. Prkacin I et al. (2001). Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent,… [PMID: 11595453]

    Laboratory literature summary: Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  176. Ilic S et al. (2011). Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric… [PMID: 21645505]

    Laboratory literature summary: Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  177. Staresinic M et al. (2006). Effective research protocol of transected quadriceps muscle in rat: Gastric… [PMID: 16609979]

    Laboratory literature summary: Effective research protocol of transected quadriceps muscle in rat: Gastric pentadecapeptide BPC 157. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  178. Sikiric P (1999). The pharmacological properties of the novel peptide BPC 157 (PL-10) [PMID: 17657443]

    Laboratory literature summary: The pharmacological properties of the novel peptide BPC 157 (PL-10). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  179. Hrelec M et al. (2009). Abdominal aorta anastomosis in rats and stable gastric pentadecapeptide BPC 157,… [PMID: 20388960]

    Laboratory literature summary: Abdominal aorta anastomosis in rats and stable gastric pentadecapeptide BPC 157, prophylaxis and research protocol. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  180. Ilic S et al. (2009). Over-exposure level insulin and stable gastric pentadecapeptide BPC 157. Attenuated… [PMID: 20388953]

    Laboratory literature summary: Over-exposure level insulin and stable gastric pentadecapeptide BPC 157. Attenuated gastric ulcers, seizures, brain lesions,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  181. Sikiric P et al. (2000). The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt's test… [PMID: 10791689]

    Laboratory literature summary: The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt's test and chronic unpredictable stress in rats. A…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  182. Skorjanec S et al. (2009). Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 18649140]

    PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context. Review the full methods and limitations on PubMed; research use only.

  183. Bilic I et al. (2001). Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole,… [PMID: 11292068]

    Laboratory literature summary: Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  184. Krivic A et al. (2008). Modulation of early functional recovery of Achilles tendon to bone unit after… [PMID: 18594781]

    Laboratory literature summary: Modulation of early functional recovery of Achilles tendon to bone unit after transection by BPC 157 and methylprednisolone. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  185. Smoday IM et al. (2026). Fourier Transform Infrared Spectroscopic Characterization of Aortic Wall Remodeling by… [PMID: 41599787]

    Laboratory literature summary: Fourier Transform Infrared Spectroscopic Characterization of Aortic Wall Remodeling by Stable Gastric Pentadecapeptide BPC 157 After…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  186. Becejac T et al. (2018). An endogeous defensive concept, renewed cytoprotection/adaptive cytoprotection:… [PMID: 30279308]

    Laboratory literature summary: An endogeous defensive concept, renewed cytoprotection/adaptive cytoprotection: intra(per)-oral/intragastric strong alcohol in rat.…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  187. Sikiric P et al. (2001). Cysteamine-colon and cysteamine-duodenum lesions in rats. Attenuation by gastric… [PMID: 11595448]

    Laboratory literature summary: Cysteamine-colon and cysteamine-duodenum lesions in rats. Attenuation by gastric pentadecapeptide BPC 157, cimetidine, ranitidine,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  188. Petrovic I et al. (2006). An experimental model of prolonged esophagitis with sphincter failure in the rat and… [PMID: 17116974]

    Laboratory literature summary: An experimental model of prolonged esophagitis with sphincter failure in the rat and the investigational potential of gastric…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  189. Prkacin I et al. (2001). Portal hypertension and liver lesions in chronically alcohol drinking rats prevented… [PMID: 11595456]

    Laboratory literature summary: Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  190. Stancic-Rokotov D et al. (2001). Lung lesions and anti-ulcer agents beneficial effect: anti-ulcer agents… [PMID: 11595454]

    Laboratory literature summary: Lung lesions and anti-ulcer agents beneficial effect: anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  191. Sikiric P et al. (2000). Gastric mucosal lesions induced by complete dopamine system failure in rats. The… [PMID: 10791690]

    Laboratory literature summary: Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  192. Dobric I et al. (2007). Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat… [PMID: 17452811]

    Laboratory literature summary: Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and investigational potential of the gastric…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

Browse the full PubMed index: PubMed search.

Additional information

Weight .125 lbs
Dimensions 9 × 7 × .5 in

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

What is the Glow Blend peptide?

The Glow Blend is a combination of peptides formulated for research use. It is studied in research laboratories for its role in cellular signaling and peptide interaction pathways.

What peptides are included in the Glow Blend?

The Glow Blend contains a combination of peptides such as GHK-Cu and other related compounds studied in research laboratories for cellular and peptide-related pathways.

What is the Glow Blend used for in research?

The Glow Blend is used in research laboratories to investigate peptide interactions, cellular signaling, and tissue-related pathways. It is not approved for human use.

Is Glow | GHK-CU, TB-500, BPC-157 Blend approved or intended for human use?

No. The Glow Blend is strictly intended for research purposes only and is not approved by the FDA for human use.

Is Glow | GHK-CU, TB-500, BPC-157 Blend FDA-approved for medical or clinical use?

No. The Glow Blend is not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is the Glow Blend supplied?

The Glow Blend is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.

How should the Glow Blend be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for the Glow Blend?

The Glow Blend is available in multiple vial sizes (e.g., 5mg, 10mg).

Is Glow | GHK-CU, TB-500, BPC-157 Blend sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is the Glow Blend shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://www.nationwidepeptides.com/shipping-and-payments/

Frequently bought together

Glow | GHK-CU, TB-500, BPC-157 Blend research-grade
Glow | GHK-CU, TB-500, BPC-157 Blend
$124.00
+
Bacteriostatic Water (Bac Water) research-grade
Bacteriostatic Water (Bac Water) - 10ml
$16.00

Frequently Asked Questions

What is the Glow Blend peptide?
The Glow Blend is a combination of peptides formulated for research use. It is studied in research laboratories for its role in cellular signaling and peptide interaction pathways.
What peptides are included in the Glow Blend?
The Glow Blend contains a combination of peptides such as GHK-Cu and other related compounds studied in research laboratories for cellular and peptide-related pathways.
What is the Glow Blend used for in research?
The Glow Blend is used in research laboratories to investigate peptide interactions, cellular signaling, and tissue-related pathways. It is not approved for human use.
Is Glow | GHK-CU, TB-500, BPC-157 Blend approved or intended for human use?
No. The Glow Blend is strictly intended for research purposes only and is not approved by the FDA for human use.
Is Glow | GHK-CU, TB-500, BPC-157 Blend FDA-approved for medical or clinical use?
No. The Glow Blend is not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.
In what form is the Glow Blend supplied?
The Glow Blend is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.
How should the Glow Blend be stored?
Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.
What vial sizes are available for the Glow Blend?
The Glow Blend is available in multiple vial sizes (e.g., 5mg, 10mg).
Is Glow | GHK-CU, TB-500, BPC-157 Blend sold as a prescription product?
No prescription is required; however, it is sold strictly for research use only.
How is the Glow Blend shipped?
Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://www.nationwidepeptides.com/shipping-and-payments/
SKU: glow-70-mg Category: Tags: , , , , , Brand:

Related products